Scientists uncover new mechanism regulating fetal growth and neonatal survival

Sep 16, 2009

Dr. Sylvain Meloche, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and his colleagues have uncovered the critical role played by the protein kinase Erk3 in fetal growth potential and lung maturation. The recent findings, published in the online early edition of the Proceedings of the National Academy of Sciences, reveal that the loss of Erk3 function in the mouse leads to fetal growth restriction and early neonatal lethality caused by respiratory distress.

Respiratory distress syndrome is a serious complication of premature and intrauterine growth-restricted infants and represents the primary contributor to neonatal morbidity and mortality. Intrauterine growth restriction (IUGR) refers to a condition in which the fetus fails to achieve its genetically determined size and is consequently smaller than expected for its gestational age. It results from defects that prevent the multiplication or growth of cells, leading to a decrease in organ size and function. To date, only few molecular mechanisms have been proposed to explain this complex condition. In this study, Dr. Meloche and his team demonstrate that the inactivation of Erk3 in mice mimics IUGR conditions in humans and is associated with decreased blood levels of IGF-2, a growth hormone promoting fetal development.

"Infants with IUGR have a significant risk for diabetes, hypertension and coronary heart disease later in life," explains Dr. Meloche, "IUGR is also associated with a higher risk of long-term neurodevelopmental outcomes. We hope that this study will shed new light on the molecular mechanisms underlying this serious condition."

Dr. Meloche and his team intend to exploit this new mouse model to further the understanding of the genetic and biochemical pathways involved in control and pulmonary maturation.

More information: Sonia Klinger, Benjamin Turgeon, Kim Lévesque, Geoffrey A. Wood, Kjersti M. Aagaard-Tillery, and Sylvain Meloche. Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality. PNAS published online before print September 15, 2009, doi:10.1073/pnas.0900919106

Source: University of Montreal (news : web)

Explore further: The impact of bacteria in our guts

add to favorites email to friend print save as pdf

Related Stories

Genetic mutations may contribute to preterm birth risk

Jan 31, 2008

Genetic mutations in the enzyme methylenetetrahydrofoloate reductase (MTHFR) and coagulation protein Factor V appear to have significant association with blood clots and tissue injury to the placenta and developing baby, ...

Recommended for you

The impact of bacteria in our guts

Aug 22, 2014

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

Aug 22, 2014

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

Aug 22, 2014

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments : 0